Company / R&D per Share
iRhythm Holdings, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.70
FY2025
5-year range
$1.33 / $2.70
FY2021-FY2025
Trend
+16.8%
vs FY2024
Sector context
#31 of 103
Health Care
What the data says
At $2.70, iRhythm Holdings, Inc.'s r&d per share ranks #31 of 103 in the Health Care sector. R&D per Share has increased for 4 consecutive years, from $1.33 in FY2021 to $2.70 in FY2025.
Based on SEC 10-K filings.
2.70 in FY2025 with a 5-year CAGR of +11.7%.
Improved from $2.00 to $2.70 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +19.5%
- 5-Year CAGR
- +11.7%
- 10-Year CAGR
- -
Sector benchmark
#31 of 103 in Health CareTop 30% of 103This company $2.70 Sector average $2.13
▼
+26.4% above sector average
Key checks
Key Insights
- iRhythm Holdings, Inc.'s r&d per share has grown for 4 consecutive years.
- In FY2025, r&d per share increased 16.8% year-over-year.
- Ranks #31 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- Negative profit margin: -19.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.70 | +16.8% |
| FY2024 | $2.31 | +15.7% |
| FY2023 | $2.00 | +26.3% |
| FY2022 | $1.58 | +18.6% |
| FY2021 | $1.33 | -14.0% |
| FY2020 | $1.55 | +1.2% |
| FY2019 | $1.53 | +71.5% |
| FY2018 | $0.89 | +48.9% |
| FY2017 | $0.60 | -88.2% |
| FY2016 | $5.07 | +9.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026